A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients.
about
Alcoholism: A Systems Approach From Molecular Physiology to Addictive BehaviorFuture pharmacological treatments for substance use disordersAddiction science: Uncovering neurobiological complexityOpioid antagonists for alcohol dependenceOpioid antagonists for alcohol dependenceThe genetic basis of addictive disordersThe role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical reviewReview. The neurobiology of pathological gambling and drug addiction: an overview and new findingsAn evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) studyAlcohol response and consumption in adolescent rhesus macaques: life history and genetic influencesAdvances in Medications and Tailoring Treatment for Alcohol Use DisorderAlcohol liver disease: A review of current therapeutic approaches to achieve long-term abstinenceCurrent status of co-occurring mood and substance use disorders: a new therapeutic targetImproving clinical outcomes for naltrexone as a management of problem alcohol useMedications for unhealthy alcohol use: across the spectrum.A pilot trial of low-dose naltrexone in primary progressive multiple sclerosisTargeted opioid receptor antagonists in the treatment of alcohol use disordersSymbiotic relationship of pharmacogenetics and drugs of abuse.The dual orexin/hypocretin receptor antagonist, almorexant, in the ventral tegmental area attenuates ethanol self-administrationVariation at the rat Crhr1 locus and sensitivity to relapse into alcohol seeking induced by environmental stressChronic ethanol exposure produces tolerance to elevations in neuroactive steroids: mechanisms and reversal by exogenous ACTHBreaking barriers in the genomics and pharmacogenetics of drug addictionMedication treatment of different types of alcoholism.Challenges and opportunities for medications development in alcoholism: an international perspective on collaborations between academia and industry.Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings.A synopsis of the pharmacological rationale, properties and therapeutic effects of depot preparations of naltrexone for treating alcohol dependence.Naltrexone long-acting formulation in the treatment of alcohol dependence.Addressing tobacco use disorder in smokers in early remission from alcohol dependence: the case for integrating smoking cessation services in substance use disorder treatment programsDSM-5 criteria for substance use disorders: recommendations and rationaleA polymorphism in the OPRM1 3'-untranslated region is associated with methadone efficacy in treating opioid dependenceProton magnetic resonance spectroscopy in alcohol use disorders: a potential new endophenotype?Microarray studies of psychostimulant-induced changes in gene expression.Association between single nucleotide polymorphisms in the mu opioid receptor gene (OPRM1) and self-reported responses to alcohol in American Indians.The behavioral, anatomical and pharmacological parallels between social attachment, love and addiction.Pharmacogenetics of OPRM1.Clinical Case Discussion: Pathological Gambling and Nicotine Dependence.Genetic influences on response to alcohol and response to pharmacotherapies for alcoholism.Drug-induced and genetic alterations in stress-responsive systems: Implications for specific addictive diseases.Metabolomics biomarkers to predict acamprosate treatment response in alcohol-dependent subjects.Exposure to the taste of alcohol elicits activation of the mesocorticolimbic neurocircuitry.
P2860
Q22241964-5FA757C1-34AA-4DE3-9572-A28F9663D886Q22242633-0E837CAE-D96D-4FE3-8D06-8A1238FCE14DQ22251251-312F4FD6-6CDB-4352-B47F-4C7FB26841A6Q24235797-5C9FD223-EA78-4930-AC41-DA13770AA658Q24244900-F8DC3240-357A-4FC3-BAED-E7C4D9A2DAA4Q24607129-1AA099F5-78BB-40FF-ACC0-D2AD4D6DF086Q24616528-A551623F-9C73-4B62-97BC-769717B0F7C0Q24641954-7C89718C-9900-436A-B26A-3809B1DD20C4Q24645469-0FCF49B3-5FF5-4C09-9355-D89EBF925977Q24652359-34B6EDD0-642F-49F7-ACDC-19EDD3AF4B24Q26799814-0806FAB9-5F27-4CF9-8164-4CE76D50C280Q26801196-D723D62B-E402-4328-807E-6E5DF6D2A61FQ27014938-8599F341-CE77-413D-864F-2E6224B0E254Q27021406-973FC7DE-EF59-4DC6-BBDA-A8C1D45AC997Q27690692-F1DC2876-D520-4B79-BBDC-58AA5EDAEE48Q28291875-55158BBA-D297-4BCD-A33D-E7B90C894F2CQ28295125-D0CE5A2A-A494-4DF4-8301-0B3C78AA12D7Q28476270-1D6215F9-959A-4970-9E6D-9BBD0EC1B512Q28483933-A31281CA-F7F9-4426-9F3F-C87A3272C77CQ28578368-C2E47AEF-C36F-44BD-825F-98A1AAFED177Q28582398-B4023690-3D88-445E-984F-FCE8A2F6556FQ30417717-596B0188-A60F-4C7F-961A-22EBE0BE1288Q30434793-C0B9ACF5-48E8-4B9B-B140-969A666FB58CQ30438009-BA141334-5BA8-448E-9487-18BBA7C3483FQ30440516-5EDED798-D37A-4647-8954-EA3548015451Q30440554-6FDFD1D7-44F9-4B5A-831A-7B730C526D07Q30441807-F3733662-BD19-479F-96A3-920C1CFE84DEQ30477221-DD146B62-4064-46DF-8D23-C7FF3A5C0F2EQ30544314-0E028CC8-2867-48E0-9E8A-FA9B119717BDQ30855550-BE3D61E2-11D9-4FA1-B118-5E6BD625C809Q31158547-F3CB3FDA-3CCA-457A-9CD4-8FBB9CF89C93Q33214334-501A2B6D-41F0-44D3-83F2-F4841F6B4175Q33330500-90AA26DF-F133-4E51-B31E-93E7C5589359Q33455500-C7664F29-48DB-4B87-9FA9-B5440AC19B81Q33568294-5ECF0B6E-112C-4A1B-8D20-8FFBD3549965Q33588856-C98726C1-8787-47B8-BBA2-24CFF37270BBQ33591091-CB545EB9-2739-47CB-9531-54DFC45D3309Q33643136-B2A231F2-99BF-41BA-97C2-3B7861B325CFQ33746846-2EAA3051-246A-4E2E-8D75-2E3B8861C127Q33797940-1640F550-07AB-4326-9710-5D11B572C9D4
P2860
A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
A functional polymorphism of t ...... in alcohol-dependent patients.
@en
A functional polymorphism of t ...... in alcohol-dependent patients.
@nl
type
label
A functional polymorphism of t ...... in alcohol-dependent patients.
@en
A functional polymorphism of t ...... in alcohol-dependent patients.
@nl
prefLabel
A functional polymorphism of t ...... in alcohol-dependent patients.
@en
A functional polymorphism of t ...... in alcohol-dependent patients.
@nl
P2093
P2860
P921
P356
P1476
A functional polymorphism of t ...... in alcohol-dependent patients.
@en
P2093
Charles P O'Brien
David W Oslin
Helen Pettinati
Henry R Kranzler
Joseph R Volpicelli
Wade Berrettini
P2860
P2888
P304
P356
10.1038/SJ.NPP.1300219
P407
P577
2003-06-18T00:00:00Z